MYC and B-cell non-Hodgkin lymphoma: This proves that the senescence-inducing cell cycle regulator p21Cip1 was strictly required to prevent the transition of pre-malignant B cells into B-cell lymphomas in ICB-treated λ-MYC mice, and that ICB-mediated p21Cip1 activation was IFN-γ-dependent.